Inventor · disambiguated record
Pei-Pei Kung
Also filed as: KUNG PEI-PEI
25 granted patents·17 pending applications·351 citations·filing 1995–2025
96Inventor score
Top patents by PatentIndex Score
42 records- 0196US9481666B2Substituted dihydroisoquinolinone compoundsPFIZER·Filed 2015·Granted Nov 1, 2016·12 cites·8 claims
- 0294US11492346B2Benzisoxazole sulfonamide derivativesPFIZER·Filed 2020·Granted Nov 8, 2022·5 cites·6 claims
- 0394US7858643B2Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitorsAGOURON PHARMA·Filed 2005·Granted Dec 28, 2010·28 cites·2 claims
- 0493US8106197B2Aminoheteroaryl compounds as protein kinase inhibitorsCUI JINGRONG JEAN·Filed 2006·Granted Jan 31, 2012·48 cites·11 claims
- 0593US6156758AAntibacterial quinazoline compoundsISIS PHARMACEUTICALS INC·Filed 1999·Granted Dec 5, 2000·68 cites·17 claims
- 0692US7230098B2Aminoheteroaryl compounds as protein kinase inhibitorsSUGEN INC·Filed 2004·Granted Jun 12, 2007·73 cites·15 claims
- 0789US9040515B2Aryl and heteroaryl fused lactamsPFIZER·Filed 2013·Granted May 26, 2015·13 cites·17 claims
- 0889US7465842B2Enantioselective biotransformation for preparation of protein tyrosine kinase inhibitor intermediatesAGOURON PHARMA·Filed 2005·Granted Dec 16, 2008·15 cites·16 claims
- 0987US10570121B2Substituted dihydroisoquinolinone compoundsPFIZER·Filed 2018·Granted Feb 25, 2020·2 cites·4 claims
- 1086US10246433B2Aryl and heteroaryl fused lactamsPFIZER·Filed 2017·Granted Apr 2, 2019·5 cites·16 claims
- 1186US6150129AAntimicrobial determination of N-(aminoalkyl) and/or N-(Amidoalkyl) dinitrogen heterocyclic compositionsISIS PHARMACEUTICALS INC·Filed 1998·Granted Nov 21, 2000·34 cites·25 claims
- 1282US8785632B2Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitorsCUI JINGRONG JEAN·Filed 2012·Granted Jul 22, 2014·5 cites·4 claims
- 1379US10125130B2Cycloalkyl-linked diheterocycle derivativesPFIZER·Filed 2017·Granted Nov 13, 2018·2 cites·21 claims
- 1475US12371425B2Benzisoxazole sulfonamide derivativesPFIZER·Filed 2022·Granted Jul 29, 2025·0 cites·4 claims
- 1574US2025122183A1Nitrogen-Linked Benzisoxazole Sulfonamide DerivativesPFIZER·Filed 2024·Application pending·0 cites
- 1673US10676471B2Cycloalkyl-linked diheterocycle derivativesPFIZER·Filed 2019·Granted Jun 9, 2020·0 cites·2 claims
- 1767US5731438AN-(aminoalkyl)-and/or N-(amidoalkyl)-dinitrogen heterocyclesISIS PHARMACEUTICALS INC·Filed 1996·Granted Mar 24, 1998·10 cites·21 claims
- 1866US2025276966A1Nitrogen-Linked Benzisoxazole Sulfonamide DerivativesPFIZER·Filed 2025·Application pending·0 cites
- 1960US2014288086A1Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitorsCUI JINGRONG JEAN·Filed 2014·Application pending·0 cites
- 2059US2016376254A1Substituted dihydroisoquinolinone compoundsPFIZER·Filed 2016·Application pending·0 cites
- 2159US2025049802A1Combination therapies and uses for treating cancerPFIZER·Filed 2022·Application pending·0 cites
- 2258US2019040055A1Cycloalkyl-Linked Diheterocycle DerivativesPFIZER·Filed 2018·Application pending·0 cites
- 2357US2017298048A1Substituted dihydroisoquinolinone compoundsPFIZER·Filed 2017·Application pending·0 cites
- 2452US6207826B1Macrocyclic compounds having nitrogen-containing linkagesISIS PHARMACEUTICALS INC·Filed 1995·Granted Mar 27, 2001·5 cites·6 claims
- 2552US2010324061A1Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitorsAGOURON PHARMA·Filed 2010·Application pending·0 cites
- 2651US2015239842A1Benzamide and heterobenzamide compoundsPFIZER·Filed 2013·Application pending·0 cites
- 2748US6107482ANitrogenous macrocyclic compoundsISIS PHARMACEUTICALS INC·Filed 1996·Granted Aug 22, 2000·6 cites·6 claims
- 2848US2017050958A1Cycloalkyl-Linked Diheterocycle DerivativesPFIZER·Filed 2015·Application pending·0 cites
- 2947US2010093696A12-amino pyrimidine compoundsPFIZER·Filed 2008·Application pending·0 cites
- 3046US2017152239A1Benzamide and heterobenzamide compoundsPFIZER·Filed 2017·Application pending·0 cites
- 3146US2015175572A1Aryl and heteroaryl fused lactamsPFIZER·Filed 2015·Application pending·0 cites
- 3245US8080556B22-amino pyrimidine compounds as potent HSP-90 inhibitorsKUNG PEI-PEI·Filed 2009·Granted Dec 20, 2011·0 cites·16 claims
- 3345US2009215742A1Amide resorcinol compoundsPFIZER·Filed 2006·Application pending·0 cites
- 3444US11529344B2EZH2 inhibitor combination therapiesPFIZER·Filed 2018·Granted Dec 20, 2022·0 cites·8 claims
- 3544US6121433AOligomeric compounds having nitrogen-containing linkagesISIS PHARMACEUTICALS INC·Filed 1995·Granted Sep 19, 2000·8 cites·13 claims
- 3643US5998419AN-(aminoalkyl)- and/or N-(amidoalkyl)-dinitrogen heterocyclesISIS PHARMACEUTICALS INC·Filed 1998·Granted Dec 7, 1999·4 cites·17 claims
- 3742US2006178374A1Aminoheteroaryl compounds as protein kinase inhibitorsAGOURON PHARMA·Filed 2005·Application pending·0 cites
- 3842US2006128724A1Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitorsAGOURON PHARMA·Filed 2005·Application pending·0 cites
- 3940US6660466B1Di-nitrogen heterocycle compositionsISIS PHARMACEUTICALS INC·Filed 1998·Granted Dec 9, 2003·1 cites·8 claims
- 4039US5798360AN-(aminoalkyl)- and/or N-(amidoalkyl)- dinitrogen heterocyclic compositionsISIS PHARMACEUTICALS INC·Filed 1996·Granted Aug 25, 1998·4 cites·24 claims
- 4135US2004043959A1Combination therapies for treating methylthioadenosine phosphorylase deficient cellsFiled 2003·Application pending·0 cites
- 4234US5817489ADi-nitrogen heterocycle compositionsISIS PHARMACEUTICALS INC·Filed 1996·Granted Oct 6, 1998·3 cites·66 claims
Join the waitlist — get patent alerts
Get an alert when Pei-Pei Kung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →